Nicotinamide in Hemodialysis Patients With Hyperphosphatemia
Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
Study hypothesis: Nicotinamide inhibits gastrointestinal phosphate absorption and serum
phosphate levels of dialysis patients in a dose dependent manner.